These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7548539)

  • 1. Antibiotic effects on bacterial viability, toxin production, and host response.
    Stevens DL; Bryant AE; Hackett SP
    Clin Infect Dis; 1995 Jun; 20 Suppl 2():S154-7. PubMed ID: 7548539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of antibiotics on toxin production and viability of Clostridium perfringens.
    Stevens DL; Maier KA; Mitten JE
    Antimicrob Agents Chemother; 1987 Feb; 31(2):213-8. PubMed ID: 2882731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of clindamycin, rifampin, tetracycline, metronidazole, and penicillin for efficacy in prevention of experimental gas gangrene due to Clostridium perfringens.
    Stevens DL; Maier KA; Laine BM; Mitten JE
    J Infect Dis; 1987 Feb; 155(2):220-8. PubMed ID: 2879873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced production of phospholipase C and perfringolysin O (alpha and theta toxins) in a gatifloxacin-resistant strain of Clostridium perfringens.
    Rafii F; Park M; Bryant AE; Johnson SJ; Wagner RD
    Antimicrob Agents Chemother; 2008 Mar; 52(3):895-900. PubMed ID: 18160514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antibiotic susceptibility pattern of gas gangrene-forming
    Sárvári KP; Schoblocher D
    Infect Dis (Lond); 2020 Mar; 52(3):196-201. PubMed ID: 31778089
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of single and combination antimicrobial agents for prevention of experimental gas gangrene caused by Clostridium perfringens.
    Stevens DL; Laine BM; Mitten JE
    Antimicrob Agents Chemother; 1987 Feb; 31(2):312-6. PubMed ID: 2882732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy of experimental (murine) Clostridium perfringens type A gas gangrene.
    Traub WH
    Chemotherapy; 1988; 34(6):472-7. PubMed ID: 2907452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In vitro susceptibility of Clostridium perfringens to 6 antimicrobial agents].
    Fernández H; Toledo G
    Rev Med Chil; 1982 Nov; 110(11):1110-2. PubMed ID: 6306749
    [No Abstract]   [Full Text] [Related]  

  • 9. Clostridium perfringens type A. Comparison of in vitro and in vivo activity of twelve antimicrobial drugs.
    Traub WH
    Chemotherapy; 1986; 32(1):59-67. PubMed ID: 2868848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A note on the antibiotic susceptibilities of Clostridium perfringens serotypes isolated from meat.
    Smart JL; Truman ML; Stringer MF
    J Appl Bacteriol; 1983 Feb; 54(1):135-9. PubMed ID: 6303997
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical pharmacology of antibiotic agents.
    Pallasch TJ; Gill CJ; Kunitake LM
    CDA J; 1986 May; 14(5):70-9. PubMed ID: 3085959
    [No Abstract]   [Full Text] [Related]  

  • 12. Antimicrobial susceptibility of canine Clostridium perfringens strains from Switzerland.
    Gobeli S; Berset C; Burgener I; Perreten V
    Schweiz Arch Tierheilkd; 2012 Jun; 154(6):247-50. PubMed ID: 22653699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamics of plc gene transcription and alpha-toxin production during growth of Clostridium perfringens strains with contrasting alpha-toxin production.
    Abildgaard L; Schramm A; Rudi K; Højberg O
    Vet Microbiol; 2009 Oct; 139(1-2):202-6. PubMed ID: 19559545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Membrane filtration in the study of antimicrobial drugs.
    Meers PD; Churcher GM
    J Clin Pathol; 1974 Apr; 27(4):288-91. PubMed ID: 4368904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance of Clostridium perfringens to beta-lactam antibiotics mediated by a decreased affinity of a single essential penicillin-binding protein.
    Williamson R
    J Gen Microbiol; 1983 Aug; 129(8):2339-42. PubMed ID: 6313857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of therapy with hyperbaric oxygen for experimental infection with Clostridium perfringens.
    Stevens DL; Bryant AE; Adams K; Mader JT
    Clin Infect Dis; 1993 Aug; 17(2):231-7. PubMed ID: 8399871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative efficacy of antibiotics in treating experimental Clostridium septicum infection.
    Aldape MJ; Bayer CR; Rice SN; Bryant AE; Stevens DL
    Int J Antimicrob Agents; 2018 Oct; 52(4):469-473. PubMed ID: 30012441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility of Clostridium perfringens isolated from human infections to twenty antibiotics.
    Schwartzman JD; Reller LB; Wang WL
    Antimicrob Agents Chemother; 1977 Apr; 11(4):695-7. PubMed ID: 193441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of antimicrobial resistance and resistance transfer in anaerobic bacteria.
    Tally FP; Malamy MH
    Scand J Infect Dis Suppl; 1982; 35():37-44. PubMed ID: 6300995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction between penicillin, clindamycin or metronidazole and gentamicin against species of clostridia and anaerobic and facultatively anaerobic gram-positive cocci.
    Brook I; Walker RI
    J Antimicrob Chemother; 1985 Jan; 15(1):31-7. PubMed ID: 3972757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.